Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions
Date
2017Author
Cirali, Ilknur Calpar
Yildiz, Ahmet
Sinan, Umit Yasar
Oktay, Veysel
Ersanli, Murat Kazim
Metadata
Show full item recordAbstract
Objective: Discontinuation of metformin treatment in patients scheduled for elective coronary angiography (CAG) is controversial because of post-procedural risks including acute contrast-induced nephropathy (CIN) and lactic acidosis (LA). This study aims to discuss the safety of continuing metformin treatment in patients undergoing elective CAG with normal or mildly impaired renal functions.
Collections
- Makale [92796]